复元活血固肾方联合常规西药治疗抗磷脂综合征复发性流产临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R714.21

基金项目:

国家卫生发展科研专项项目(22-8-3-1-YHC)


Clinical Study on Fuyuan Huoxue Gushen Prescription Combined with Routine West⁃ ern Medicine for Recurrent Spontaneous Abortion with Antiphospholipid Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察复元活血固肾方对抗磷脂综合征复发性流产的抗凝作用及外周血髓样分化因子 88(MyD88)、Toll 样受体-4(TLR-4) 表达的影响。方法:选择抗磷脂综合征复发性流产患者100 例,按随 机数字表法分为对照组和观察组各50 例。对照组给予常规治疗,观察组在对照组基础上给予复元活血固肾方 治疗。比较2 组治疗前、孕10 周细胞间黏附分子-1 (ICAM-1)、血管细胞黏附分子-1(VCAM-1)、白细 胞介素-35(IL-35)、血管内皮生长因子(VEGF)、抗β2糖蛋白I 抗体(anti-β2-GPI) 及TLR4/MyD88 mRNA 表 达水平,检测T 淋巴细胞CD4+、CD8+、免疫球蛋白M(IgM)、活化部分凝血酶原时间(APTT) 水平及血小板 聚集率,检测子宫动脉博动指数(PI)、动脉收缩期/舒张末期流速(S/D)、动脉阻力指数(RI),记录2 组自 然流产率、成功分娩率。结果:孕10 周,2 组MyD88 mRNA、TLR-4 mRNA 表达较治疗前降低(P<0.05), 观察组MyD88 mRNA、TLR-4 mRNA 表达低于对照组(P<0.05)。孕10 周,2 组ICAM-1、VCAM-1、IgM、 CD4+、anti-β2-GPI、血小板聚集率较治疗前降低(P<0.05),观察组ICAM-1、VCAM-1、IgM、CD4+、anti- β2-GPI、血小板聚集率低于对照组(P<0.05);2 组IL-35、VEGF、APTT、CD8+含量较治疗前升高(P< 0.05),观察组IL-35、VEGF、APTT、CD8+含量高于对照组(P<0.05)。孕10 周,2 组PI、RI、S/D 较治疗 前降低(P<0.05),观察组PI、RI、S/D 低于对照组(P<0.05)。观察组成功分娩率(96.00%) 高于对照 组(78.00%)(P<0.05),观察组自然流产率(4.00%) 低于对照组(22.00%)(P<0.05)。结论:复元活血固 肾方治疗抗磷脂综合征复发性流产患者,可调节TLR-4/MyD88 信号通路,抑制炎症反应,减少血管内皮损 伤,改善患者免疫功能,提升抗凝作用,改善子宫动脉血流及妊娠结局。

    Abstract:

    Abstract: Objective: To observe the anticoagulant effect of Fuyuan Huoxue Gushen Prescription combined with routine western medicine for recurrent spontaneous abortion with antiphospholipid syndrome and expressions of myeloid differentiation factor 88 (MyD88) and toll-like receptor 4 (TLR- 4) in peripheral blood. Methods: A total of 100 cases of patients with recurrent spontaneous abortion with antiphospholipid syndrome were selected and divided into the control group and the observation group according to the random number table method,with 50 cases in each group. The control group was given routine treatment, and the observation group was additionally treated with Fuyuan Huoxue Gushen Prescription based on the treatment of the control group. Before treatment and at 10 weeks of pregnancy, the levels of intercellular adhesion molecule- 1 (ICAM- 1),vascular cell adhesion molecule- 1 (VCAM- 1), interleukin- 35 (IL-35),vascular endothelial growth factor (VEGF),anti-β2-glycoprotein I (anti- β2-GPI), and TLR4/MyD88 mRNA expression in the two groups were compared; the levels of T lymphocytes including CD4+ and CD8+ ,immunoglobulin M (IgM),and activated partial thromboplastin time (APTT),and platelet aggregation rates were detected;the pulsatility index (PI),systolic/diastolic end flow ratio (S/D), resistance index (RI) in uterine artery were tested. The spontaneous abortion rates and successful delivery rates were recorded in the two groups. Results: At 10 weeks of pregnancy, the mRNA expressions of MyD88 and TLR- 4 in the two groups were decreased when compared with those before treatment (P< 0.05),and the mRNA expressions of MyD88 and TLR-4 in the observation group were lower than those in the control group (P<0.05). At 10 weeks of pregnancy,ICAM- 1,VCAM- 1,IgM,CD4+,anti- β2-GPI and platelet aggregation rates in the two groups were decreased when compared with those before treatment (P<0.05),and ICAM-1,VCAM-1,IgM,CD4+,anti-β2-GPI and platelet aggregation rate in the observation group were lower than those in the control group (P<0.05); the contents of IL- 35, VEGF,APTT,and CD8 + in the two groups were increased when compared with those before treatment (P<0.05),and the contents of IL-35,VEGF,APTT,and CD8+ in the observation group were higher than those in the control group (P<0.05). At 10 weeks of pregnancy, the PI, RI, and S/D in the two groups were decreased when compared with those before treatment (P<0.05),and the PI,RI,and S/D in the observation group were lower than those in the control group (P<0.05). The successful delivery rate was 96.00% in the observation group, higher than that of 78.00% in the control group (P<0.05), and the spontaneous abortion rate was 4.00% in the observation group,lower than that of 22.00% in the control group (P<0.05). Conclusion:Fuyuan Huoxue Gushen Prescription for patients with recurrent spontaneous abortion with antiphospholipid syndrome can regulate their TLR- 4/MyD88 signal pathway, inhibit inflammatory reactions, reduce vascular endothelial damage, enhance anticoagulation, and improve immune responses,uterine artery blood flow and pregnancy outcome.

    参考文献
    相似文献
    引证文献
引用本文

杨苗苗,丁宁敏,马瑶.复元活血固肾方联合常规西药治疗抗磷脂综合征复发性流产临床研究[J].新中医,2023,55(13):114-119

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-07-14
  • 出版日期:
文章二维码